Mayo Clinic · 2 months ago
Business Development Manager II - Commercialization
Rochester, MN, United States
Full-time
Hybrid
Mid, Senior Level
$132K/yr - $191K/yrMayo Clinic is a leading healthcare organization, and they are seeking a Business Development Manager II to manage the commercialization potential of assigned disclosures and inventions. This role involves evaluating, negotiating agreements, and leading licensing efforts while collaborating with various stakeholders.
BiotechnologyHealth CareHospitalMedicalWellness
No H1B
Responsibilities
Evaluate and manage the commercialization potential and processing of assigned disclosures and inventions
Engage and consult with Sr. Licensing managers and Licensing Directors when appropriate
Responsible for the various stages of evaluation, patent prosecution and licensing of the assigned projects
Negotiate agreements and other commercialization efforts
Act as licensing team lead, utilizing strong leadership qualities, team management and interpersonal skills
Orient existing research and clinical departments and outside companies to Mayo Clinic Ventures
Interact with inventors, patent attorneys and licensees
Qualification
Required
Evaluate and manage the commercialization potential and processing of assigned disclosures and inventions
Engage and consult with Sr. Licensing managers and Licensing Directors when appropriate
Responsible for the various stages of evaluation, patent prosecution and licensing of the assigned projects
Negotiate agreements and other commercialization efforts
Act as licensing team lead
Utilize strong leadership qualities, team management and interpersonal skills
Possess broad technical knowledge to orient existing research and clinical departments and outside companies to Mayo Clinic Ventures
Interact with inventors, patent attorneys and licensees
Company
Mayo Clinic
MayoClinic is a nonprofit medical practice and medical research group focused on integrated health care, education, and research.
Founded in 1864
10001+ employees
Funding
Current Stage
Late StageTotal Funding
$399.05MKey Investors
The ALS AssociationNational Institute of Neurological Disorders and StrokeAmerican Heart Association
2025-12-04Grant· $0.95M
2024-09-24Grant· $12M
2023-07-26Grant
Leadership Team
Gianrico Farrugia
President and CEO
Richard Gray
Chief Executive Officer
Recent News
Medical Xpress - latest medical and health news stories
2026-01-16
2026-01-16
Company data provided by crunchbase